Many patients over the age of 55 with end stage renal disease in the United Kingdom are denied dialysis or transplantation. Although the reasons are complex, anticipation of a poor prognosis for these patients might explain why most British renal units impose an arbitrary age limit on the acceptance of patients for treatment. A study was therefore conducted to examine the prognosis and quality of life of 64 patients (mean age 59-6 years, range 55-72) accepted into our renal replacement programme from the beginning of 1975. The five year survival of the patients was 62 0%, with 78 1% of the survivors either having successful transplants or caring for themselves using home haemodialysis or continuous ambulatory peritoneal dialysis.
The results show that in terms of survival, economics, and rehabilitation it is both feasible and reasonable to Introduction The renal failure service in the United Kingdom is notorious for its inability to treat enough patients with end stage renal disease.) Middle aged (55-65 years) and elderly patients ( >65) fare particularly badly, as only 18% of renal units in Britain2 do not impose an age limit on the acceptance of patients for treatment. Britain provides treatment for less than one third of the number of middle aged and less than one twelfth of the number of elderly patients with end stage renal disease who are treated in neighbouring large European countries such as West Germany, France, and Italy, although the incidence of the disease in these age groups is the same in Britain as in these other countries. 3 Various reasons for failure to treat these patients aged over 55 (and in some areas, also patients aged under 55) have been suggested.4 These include lack of resources, shortage of kidneys for transplantation, selection of patients by nephrologists, and failure of general physicians to refer patients to renal units. Anticipation of a poor prognosis for these middle aged and elderly patients and concern about their quality of life may be other factors in allowing arbitrary age limits to persist as a criterion of patient selection.
The purpose of this paper is to establish the prognosis and degree of rehabilitation of patients aged 55 and over treated for end stage renal disease in our renal unit from the beginning of 1975. 
Patients

Results
At the end of the study 44 patients (6888%) were alive and 20 had died. Table III lists the causes of death. Figure 1 shows the cumulative survival of our patients, irrespective of the modes of treatment, and also the survival of patients in the same age group reported to the European Dialysis and Transplant Association in 1981.7 Figure 2 shows the cumulative survivals of the patients given transplants and of their first cadaver allografts and also the survival of patients reported to the European Dialysis and Transplant Association in 19817 after their first cadaver allograft operation. The five year survival of patients who were not given transplants (61-5%) was similar to that of patients who were given transplants (61-9%). Figure 1 shows Despite the fact that in our series most deaths were associated with transplantation, the patients with transplants nevertheless had a five year survival of 61-9%, which was closely similar to the survival of patients who were not given transplants (615%). These data are particularly impressive when compared with those of the registry of the European Dialysis and Transplant Association, which in 19817 reported that the five year survival of patients in this age group after a first cadaver graft was only 32-9% (fig 2) . We now use a low dose steroid regimen5 in all patients, which is not associated with increased graft loss, and we hope that the mortality and morbidity associated with infection and other steroid induced side effects after transplantation will decline. Graft survival in our middle aged and elderly patients was also good (66-7% at one year, 5644% at five years) and compared well with results obtained in other large single centres, such as in Minneapolis,8 which in 1981 reported cadaver allograft survival rates of 43% at two years and 320% at four years in patients aged 50 or more. In our series the few patients aged 65 and over at the start of treatment did particularly well. None died, and at the end of the study five of the six were aged 70 or more. Two had successful transplants, and only one was receiving permanent hospital haemodialysis.
At the time of their deaths or at the conclusion of the study on 31 August 1982 most of our patients (79.5%) either had functionary transplants or were caring for themselves using home haemodialysis or continuous ambulatory peritoneal dialysis. This represents a considerable economic success, as the most expensive form of treatment for end stage renal disease is hospital haemodialysis. Forty four of our patients (68 8%) were either in full time employment or retired or unemployed but fit and well. Only eight patients (12 5%) were greatly disabled, so that, in terms of rehabilitation, our patients did extremely well.
Why, then, are most middle aged and elderly patients with end stage renal disease denied treatment in Britain? We have no reason to believe that the prognosis of patients treated in our unit is any different from that of similar patients treated in other units in Britain.
Plainly the anticipation of a poor prognosis should not be a major factor in the failure to treat these patients. The chronic lack of resources and funds allocated to the treatment of end stage renal disease is a more likely explanation for this evil practice.' Attitudes towards referring patients with the disease to renal units for treatment also play an important part. Data from the South East and South West Thames Regional Health Authorities for 1982 showed that in those regions only 25 new patients per million population are accepted a year for treatment of end stage renal disease yet the most conservative estimate of the number of patients in those regions developing the disease is twice that number. Since we refuse very few patients we conclude that many with end stage renal disease are not being referred to' us by colleagues. Most of the referring (or nonreferring) physicians have no experience of dialysis or transplantation and cannot assess the suitability of patients for treatment. We are, therefore, certain that a large number of patients dying of end stage renal disease in Britain are being denied proper assessment, let alone treatment. Nor are British nephrologists blameless; many practise a form of triage, which has received international criticism.' The recent report by the Royal College of Physicians9 on the reasons why patients under the age of 50 were refused treatment for end stage renal disease is a shameful exposure of this practice.
What should be done? Our report does not suggest that all patients with end stage renal disease should be accepted for treatment, nor that treatment should be continued in the face of overwhelming medical contraindications.
Firstly, we suggest that middle aged and elderly patients with end stage renal disease should be referred to their local renal unit for assessment and possible treatment.
Secondly, the resources to treat these patients must be made available by government, preferably at a regional level, since renal units operate on a regional basis and should not have to compete for district resources simply because accidents of geography place the unit in one particular district. Possibly some of the resources allocated to the treatment of the elderly chronically ill should be diverted to the highly successful treatment of the elderly chronically ill with end stage renal disease.
Thirdly, the facilities for hospital haemodialysis must be increased. There is a shortage of kidneys available for transplantation and some patients are not suitable for this treatment. Continuous ambulatory peritoneal dialysis is a new technique with a high incidence of failure,'0 and only a few patients can perform long term home haemodialysis, as our report shows. There are therefore a number of patients who are unsuitable for these forms of treatment and will survive only if offered hospital haemodialysis. During the past 10 years there has been virtually no expansion of the hospital haemodialysis facilities in Britain, which is in stark contrast with programmes in other countries in Western Europe, the United States, and Australia. These facilities in Britain have long been saturated, and although the provision of extra resources for transplantation and continuous ambulatory peritoneal dialysis is extremely important, it is vital that there should be a substantial increase in facilities available for hospital haemodialysis.
Finally, the public must be made aware that the treatment of middle aged and elderly patients with end stage renal disease is not only feasible but successful and that medical contraindications to treatment have diminished substantially. Only political pressure will end the practice of using an arbitrary age limit as the deciding factor in selecting patients for treatment.
